关注
Joanna Kapeleris
Joanna Kapeleris
在 hdr.qut.edu.au 的电子邮件经过验证
标题
引用次数
引用次数
年份
The prognostic role of circulating tumor cells (CTCs) in lung cancer
J Kapeleris, A Kulasinghe, ME Warkiani, I Vela, L Kenny, K O'Byrne, ...
Frontiers in oncology 8, 311, 2018
1082018
The prognostic significance of circulating tumor cells in head and neck and nonsmallcell lung cancer
A Kulasinghe, J Kapeleris, R Kimberley, SR Mattarollo, EW Thompson, ...
Cancer Medicine 7 (12), 5910-5919, 2018
1032018
Phenotypic characterization of circulating lung cancer cells for clinically actionable targets
A Kulasinghe, J Kapeleris, C Cooper, ME Warkiani, K O’Byrne, ...
Cancers 11 (3), 380, 2019
342019
Ex vivo culture of circulating tumour cells derived from non-small cell lung cancer
J Kapeleris, A Kulasinghe, ME Warkiani, C Oleary, I Vela, P Leo, ...
Translational lung cancer research 9 (5), 1795, 2020
282020
Cancer stemness contributes to cluster formation of colon cancer cells and high metastatic potentials
J Kapeleris, H Zou, Y Qi, Y Gu, J Li, J Schoning, MJ Monteiro, W Gu
Clinical and Experimental Pharmacology and Physiology 47 (5), 838-847, 2020
282020
Clinical applications of circulating tumour cells and circulating tumour DNA in non-small cell lung cancer—an update
J Kapeleris, M Ebrahimi Warkiani, A Kulasinghe, I Vela, L Kenny, ...
Frontiers in oncology 12, 859152, 2022
172022
The use of three-dimensional dna fluorescent in situ hybridization (3D DNA FISH) for the detection of anaplastic lymphoma kinase (ALK) in non-small cell lung cancer (NSCLC …
A Kulasinghe, Y Lim, J Kapeleris, M Warkiani, K O’Byrne, C Punyadeera
Cells 9 (6), 1465, 2020
142020
Inhibition of colon cancer K-RasG13D mutation reduces cancer cell proliferation but promotes stemness and inflammation via RAS/ERK pathway
Y Qi, XH Zhao, F Li, ZP Xu, Y Deng, Y Tang, W Gu
Frontiers in Pharmacology 13, 996053, 2022
52022
Prognostic value of integrating circulating tumour cells and cell-free DNA in non-small cell lung cancer
J Kapeleris, JM Bark, S Ranjit, D Irwin, G Hartel, ME Warkiani, P Leo, ...
Heliyon 8 (7), 2022
42022
Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition
J Kapeleris, J Müller Bark, S Ranjit, D Richard, I Vela, K O’Byrne, ...
Journal of Cancer Research and Clinical Oncology 148 (12), 3501-3510, 2022
32022
Characterization of the tumor microenvironment and liquid biopsy in head and neck and non-small cell lung cancer
A Kulasinghe, J Kapeleris, L Kenny, B Hughes, M Warkiani, I Vela, ...
Cancer Research 80 (16_Supplement), 3384-3384, 2020
12020
Isolation, characterization and expansion of circulating tumor cells in solid cancers
A Kulasinghe, J Kapeleris, L Kenny, M Warkiani, I Vela, JP Thiery, ...
Cancer Research 79 (13_Supplement), 1333-1333, 2019
12019
Circulating tumour cells in non-small cell lung cancer
JC Kapeleris
Queensland University of Technology, 2022
2022
Abstract A03: Isolation, characterization, and expansion of circulating tumor cells in head and neck cancers
A Kulasinghe, J Kapeleris, L Kenny, M Warkiani, I Vela, JP Thiery, ...
Clinical Cancer Research 26 (12_Supplement_2), A03-A03, 2020
2020
Culture of circulating tumour cells derived from non-small cell lung cancer.
KJ O'byrne, J Kapeleris, A Kulasinghe, ME Warkiani, CG O'leary, R Ladwa, ...
Journal of Clinical Oncology 38 (15_suppl), e21692-e21692, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–15